Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Givinostat dose-finding study in polyarticular-course juvenile idiopathic arthritis
2010-019094-15Phase 2Completed
- Sponsor
- Italfarmaco
- Start
- May 2010
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of givinostat in juvenile idiopathic arthritis (JIA) (2 arms), sponsored by Italfarmaco. Primary endpoint: ACR Pediatric 30 response at 12 weeks. Started May 2010; status: completed.
02
Drugs
givinostat
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on 2010-019094-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019094-15.